Download Summary
The Netherlands reports an average score in the Policy Context category, in part due to the existence of a national asthma strategy and severe asthma guidelines. However, limited alignment of national guidelines with international best practices and tobacco control laws lowers the Netherlands’ score. In terms of Access and Care Coverage, the Netherlands scores second compared to all other countries. This is due to excellent access to treatment (including biologics), diagnostics, and telemedicine – though the Netherlands could improve access to specialist care and digital therapeutics. Notably, the Netherlands ranks among the lowest in terms of Disease Burden score. This is attributable to a high estimated societal cost of severe asthma and DALYs attributable to asthma, as well as adult tobacco use and obesity rates slightly higher than the average.
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in Netherlands
Provides further insights into how Netherlands scores across each Index category
Guidelines, strategies, and policies related to the management of severe asthma and health outcomes
60/100
Regulations and practices concerning public payor coverage for and availability of diagnostic and treatment services for severe asthma
81/100
Indicators related to clinical management and economic impact of severe asthma and recording of patient health data
54/100
Information about the health impact of severe asthma and severe asthma comorbidities
64/100
Factors impacting prevention, management, and exacerbations of severe asthma
73/100
Aggregate score across the 5 categories.
65.9/100
Explore how each of the 29 OECD countries scored in the Severe Asthma Index
Select different countries to see how they scored across each of the 5 categories and overall